A refined genome phage display methodology delineates the human antibody response in Chagas disease patients (2021)
- Authors:
- Teixeira, André Azevedo Reis
- Carnero, Luis Rodriguez
- Kuramoto, Andréia
- Tang, Fenny Hui Fen
- Gomes, Carlos Hernique
- Pereira, Natalia Bueno
- Oliveira, Lea Campos de
- Garrini, Regina
- Monteiro, Jhonatas Sirino
- Setubal, João Carlos
- Sabino, Ester Cerdeira
- Pasqualini, Renata
- Colli, Walter
- Arap,Wadih
- Alves, Maria Júlia Manso
- Cunha Neto, Edecio
- Giordano, Ricardo José
- USP affiliated authors: SETUBAL, JOÃO CARLOS - IQ ; SABINO, ESTER CERDEIRA - FM ; COLLI, WALTER - IQ ; ALVES, MARIA JULIA MANSO - IQ ; CUNHA NETO, EDECIO - FM ; GIORDANO, RICARDO JOSÉ - IQ ; MONTEIRO, JHONATAS SIRINO - BIOINFORMÁTICA
- Unidades: IQ; FM; BIOINFORMÁTICA
- DOI: 10.1016/j.isci.2021.102540
- Subjects: GENOMAS; DOENÇA DE CHAGAS; ANTÍGENOS; EPITOPOS; TRYPANOSOMA CRUZI
- Agências de fomento:
- Language: Inglês
- Imprenta:
- Source:
- Este periódico é de acesso aberto
- Este artigo é de acesso aberto
- URL de acesso aberto
- Cor do Acesso Aberto: gold
- Licença: cc-by
-
ABNT
TEIXEIRA, André Azevedo Reis et al. A refined genome phage display methodology delineates the human antibody response in Chagas disease patients. iScience, v. 24, n. 6, p. 1-27 art. 102540, 2021Tradução . . Disponível em: https://doi.org/10.1016/j.isci.2021.102540. Acesso em: 05 nov. 2024. -
APA
Teixeira, A. A. R., Carnero, L. R., Kuramoto, A., Tang, F. H. F., Gomes, C. H., Pereira, N. B., et al. (2021). A refined genome phage display methodology delineates the human antibody response in Chagas disease patients. iScience, 24( 6), 1-27 art. 102540. doi:10.1016/j.isci.2021.102540 -
NLM
Teixeira AAR, Carnero LR, Kuramoto A, Tang FHF, Gomes CH, Pereira NB, Oliveira LC de, Garrini R, Monteiro JS, Setubal JC, Sabino EC, Pasqualini R, Colli W, Arap W, Alves MJM, Cunha Neto E, Giordano RJ. A refined genome phage display methodology delineates the human antibody response in Chagas disease patients [Internet]. iScience. 2021 ; 24( 6): 1-27 art. 102540.[citado 2024 nov. 05 ] Available from: https://doi.org/10.1016/j.isci.2021.102540 -
Vancouver
Teixeira AAR, Carnero LR, Kuramoto A, Tang FHF, Gomes CH, Pereira NB, Oliveira LC de, Garrini R, Monteiro JS, Setubal JC, Sabino EC, Pasqualini R, Colli W, Arap W, Alves MJM, Cunha Neto E, Giordano RJ. A refined genome phage display methodology delineates the human antibody response in Chagas disease patients [Internet]. iScience. 2021 ; 24( 6): 1-27 art. 102540.[citado 2024 nov. 05 ] Available from: https://doi.org/10.1016/j.isci.2021.102540 - Anti-Trypanosoma cruzi antibody profiling in patients with Chagas disease treated with benznidazole assessed by genome phage display
- Recognition of Trypanosoma cruzi epitopes by IgG of benznidazole treated Chagas disease patients
- A transcriptome-based signature of pathological angiogenesis predicts breast cancer patient survival
- Protocol for design, construction, and selection of genome phage (gPhage) display libraries
- Trypanosoma cruzi binds to cytokeratin through conserved peptide motifs found in the Laminin-G-Like Domain of the gp85/trans-sialidase proteins
- Role of the gp85/trans-sialidases in Trypanosoma cruzi tissue tropism: preferential binding of a conserved peptide motif to the vasculature in vivo
- The role of Trypanosoma cruzi gp85/trans-sialidases proteins on cell cycle and survival of host cells
- Dynamic expression of Ralstonia solanacearum virulence factors and metabolism-controlling genes during plant infection
- Inference and analysis of a gene regulatory network of angiogenesis in an oxygen-induced retinopathy mouse model
- Identification of a novel cell binding peptide belonging to the gp85/transialidase superfamily
Informações sobre o DOI: 10.1016/j.isci.2021.102540 (Fonte: oaDOI API)
Download do texto completo
Tipo | Nome | Link | |
---|---|---|---|
3030570.pdf | Direct link |
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas